Inventor · disambiguated record
Manuel J. Buttini
Also filed as: BUTTINI MANUEL · BUTTINI MANUEL J
7 granted patents·11 pending applications·176 citations·filing 1998–2024
87Inventor score
Files withSCHENK DALE B7PROTHENA BIOSCIENCES LTD5ELAN PHARM INC3BLACK RONALD1JANSSEN ALZHEIMER IMMUNOTHERAP1
Top patents by PatentIndex Score
18 records- 0194US8092801B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Jan 10, 2012·44 cites·15 claims
- 0294US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 0393US8147833B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Apr 3, 2012·18 cites·4 claims
- 0491US8506959B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2005·Granted Aug 13, 2013·13 cites·15 claims
- 0583US9034337B2Treatment and delay of outset of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted May 19, 2015·7 cites·15 claims
- 0683US6046381AApolipoprotein E transgenic mice and assay methodsUNIV CALIFORNIA·Filed 1998·Granted Apr 4, 2000·53 cites·11 claims
- 0771US9272030B2Use of tau to monitor immunotherapyBLACK RONALD·Filed 2011·Granted Mar 1, 2016·1 cites·16 claims
- 0870US2021032318A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 0968US2024254211A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1066US2019300598A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 1162US2017349651A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2017·Application pending·0 cites
- 1259US2012201842A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2012·Application pending·0 cites
- 1356US2016060331A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2015·Application pending·0 cites
- 1455US2012142902A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 1553US2008014194A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseELAN PHARM INC·Filed 2007·Application pending·0 cites
- 1650US2010031377A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2005·Application pending·0 cites
- 1748US2015353631A1C-terminal and central epitope a-beta antibodiesJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2013·Application pending·0 cites
- 1847US2016184416A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuel J. Buttini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →